Multicenter phase I/II trial of adjuvant combination chemotherapy with gemcitabine and S-1 for pancreatic cancer
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 12 May 2016
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 20 Aug 2012 Planned end date changed from 1 Mar 2012 to 30 Sep 2012 as reported by University Hospital Medical Information Network - Japan.
- 20 Aug 2012 Status changed from not yet recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 08 May 2008 New trial record.